Anatara Lifesciences (ASX:ANR) is pleased to release a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, will be presenting at the Proactive Investors Australia CEO Sessions and the Wholesale Investor's Emergence 2019 conferences this month.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to announce that it has commit-ted to invest AUD1 million of ordinary equity for a 10% ownership interest in Trichomia Pty Limited.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) attaches a copy of a recent news release by MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) (OTCMKTS:MLCPF) announcing that MediPharm Labs signed a CAD35m private label cannabis oil sale agreement with an option for additional CAD13.5m.
This month, Anatara's CEO, Steve Lydeamore will be presenting to investors at events in Sydney and Melbourne. We would like to extend to you the invitation to attend.
MMJ Group Holdings Ltd (ASX:MMJ) MediPharm Labs management team changes
MMJ Group Holdings Limited (ASX:MMJ) is pleased to attach a copy of a news release confirming that Fire & Flower Inc is expected to list on the TSX Venture Exchange on or around 19 February 2019 under the trading symbol "FAF".
Anatara Lifesciences Ltd (ASX:ANR) is pleased to report positive efficacy data from its in vitro Proof of Concept studies of its Gastrointestinal ReProgramming product. GaRP is a unique natural dietary supplement designed to restore and maintain a healthy human gut and microbiome.
